EnFr
Self-injected subcutaneous DMPA: A new frontier in advancing contraceptive access and use for women
This brief details the strong body of evidence and experience with self-injection of DMPA-SC in low-resource settings, including how the practice can reduce access-related barriers, improve contraceptive continuation, and enhance women’s autonomy.
Institutional author(s): PATH
Publication date: October, 2019
-
Brief